Erythema migrans is the hallmark skin rash of early Lyme disease, caused by infection with Borrelia burgdorferi bacteria transmitted through tick bites. Its presence alone is enough to diagnose Lyme disease and start treatment, even without blood work. But the rash is widely misunderstood, and the classic “bull’s-eye” image most people picture turns out to be the exception rather than the rule, which means many cases get missed or mistaken for something else entirely.
What Erythema Migrans Actually Looks Like
If you search for erythema migrans online, the image that dominates is a neat set of concentric red rings resembling a target or bull’s-eye. That image is real, but it represents a minority of cases. The most common presentation is a uniformly red, well-defined oval patch that expands outward from the bite site. It may feel warm to the touch but often does not itch or hurt much. Over days, the patch grows, typically exceeding 5 centimeters and sometimes reaching 30 centimeters or more in diameter.1JAAD Reviews. Rethinking erythema migrans after 50 years of Lyme disease in the United States
The rash develops anywhere from a few days to about a month after a tick bite, with most appearing around seven to ten days later. Central clearing, the feature that creates the bull’s-eye look, is present in only about one in five cases among patients in endemic areas of the United States. European cases show central clearing far more often, in roughly four out of five patients.2JAMA. Does This Patient Have Erythema Migrans? This striking difference between continents reflects the different Borrelia species involved and is a major reason the rash looks different from person to person and place to place.
Less common variants add to the diagnostic confusion. Up to about 8% of cases involve blistering or fluid-filled lesions. Some develop a darker, purplish center, and others may even show tissue breakdown at the center of the rash. The lesion tends to be more oval than circular, with its long axis following skin tension lines, a quirk of how Borrelia interacts with collagen in the skin. In some patients, this elongation is dramatic enough to create triangular or irregular shapes that look nothing like the textbook pictures.3JAAD Reviews. Rethinking erythema migrans after 50 years of Lyme disease in the United States
The Bull’s-Eye Myth and Why It Matters
The gap between the classic image and reality has real consequences. In a large internet-based survey of over 3,000 people, nearly three-quarters could correctly identify the classic bull’s-eye version of erythema migrans. But when shown a uniformly red version, only about 30% recognized it as Lyme-related. The vesicular (blistering) form stumped over 80% of respondents, and more than 40% actively misidentified it as something other than Lyme disease. The disseminated form, where multiple lesions appear across the body, was recognized by fewer than 16% of participants.4PubMed Central. Bull’s-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans
These numbers matter because erythema migrans is the single most reliable early sign of Lyme disease. Waiting for the rash to develop the “right” look before seeking care means losing time during the window when treatment works best. If you find an expanding red patch at the site of a known or possible tick bite, the shape and pattern of the rash matter less than the fact that it is growing.
Why the Rash Differs Between the U.S. and Europe
Lyme disease is not caused by a single bacterium. In the United States, Borrelia burgdorferi sensu stricto is the dominant species. In Europe, at least two additional species, Borrelia afzelii and Borrelia garinii, are common culprits. These strain differences explain some of the variation in how the disease shows up, including the appearance of the rash itself.5PubMed Central. Comparison of Lyme Disease in the United States and Europe
American erythema migrans tends to present as a more uniform patch of redness. European cases more frequently display central clearing and the classic target pattern. A solitary lesion is the most common presentation on both continents, appearing in roughly 80 to 90% of cases, but the rate is slightly higher in Europe.6JAMA. Does This Patient Have Erythema Migrans? These are population-level tendencies, not guarantees, and individual cases on either continent can look like the “other” pattern. The practical lesson is that no single visual template captures all cases.
Multiple Lesions and Early Dissemination
About one in five patients develops more than one erythema migrans lesion. These multiple spots are not the result of being bitten by several ticks. Instead, they signal that the Borrelia spirochete has already spread through the bloodstream to distant skin sites, a stage called early disseminated disease.7JAAD Reviews. Rethinking erythema migrans after 50 years of Lyme disease in the United States The secondary lesions are often smaller and may lack the central punctum (the tiny mark at the original bite site). They tend to follow the same skin-tension-line orientation as solitary lesions, which can create a striking pattern across the trunk sometimes described as resembling a Christmas tree distribution.
When multiple lesions appear, they commonly come with systemic symptoms like fatigue, headache, and muscle aches.8PubMed Central. Early disseminated Lyme disease Recognizing this presentation is important because it means the infection has already progressed beyond the skin, and prompt treatment becomes even more urgent.
Diagnosis Without a Blood Test
Erythema migrans is one of the few infections where the rash itself counts as a diagnosis. If a clinician sees a characteristic expanding lesion in a patient with plausible tick exposure, standard guidelines call for starting antibiotics immediately, without waiting for lab results.9PubMed Central. Lyme Disease: An Overview This is not casual medical shortcutting; there is a specific reason blood tests are unreliable at this stage.
The standard two-tier blood test for Lyme disease measures antibodies the immune system produces against Borrelia. But antibodies take time to build up. During the acute erythema migrans phase, the sensitivity of two-tier testing is only around 30 to 40%.10PubMed Central. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States That means the majority of patients with genuine early Lyme disease will get a negative blood test if tested while the rash is still present. Sending a patient home because their blood test came back negative during this window is one of the most common clinical errors in Lyme disease management.
Direct detection methods, including skin biopsy culture and PCR testing of blood, can pick up the organism itself. In one study of 66 untreated patients with erythema migrans, at least one direct detection method was positive in about 94% of cases. Blood culture was more likely to be positive in patients with multiple lesions compared to those with a solitary rash.11PubMed Central. Comparison of Five Diagnostic Modalities for Direct Detection of Borrelia burgdorferi in Patients with Early Lyme Disease These methods are not widely available in routine clinical settings, though, which is why the clinical diagnosis based on the rash remains the practical standard.
Rashes That Mimic Erythema Migrans
An expanding red patch after a tick bite is not always Lyme disease. The most common source of confusion is Southern Tick-Associated Rash Illness, or STARI, which produces lesions that look strikingly similar to erythema migrans but follow bites from the Lone Star tick (Amblyomma americanum) rather than the blacklegged tick that carries Borrelia. Lone Star tick-associated rashes show up as expanding red patches, sometimes with central clearing. However, Lyme disease blood tests run on these patients are typically negative, and cultures fail to grow Borrelia spirochetes.12PubMed. Physician-diagnosed erythema migrans and erythema migrans-like rashes following Lone Star tick bites The cause of STARI remains uncertain, and the condition generally resolves with antibiotics as a precaution, but it is a distinct entity from Lyme disease.
Other conditions in the differential include bacterial cellulitis (which tends to be more painful and spreads more irregularly), ringworm (which usually has a scaly, raised edge), hypersensitivity reactions to insect bites (which typically peak and fade within days rather than steadily expanding), and granuloma annulare (a benign skin condition with firm, ring-shaped bumps). The expanding nature of erythema migrans is one of its most distinguishing features. A red mark from an ordinary bug bite that stays the same size or shrinks over a few days is unlikely to be erythema migrans. One that keeps growing day after day warrants attention.
Erythema Migrans on Darker Skin
Most medical training images of erythema migrans depict the rash on light skin, which creates a visibility problem with real clinical consequences. On darker skin tones, the rash may appear more violet or bruise-like rather than bright red, making it harder to spot and potentially delaying diagnosis. A review of commonly used medical student resources found that images of erythema migrans on dark skin were rare and appeared almost exclusively in web-based materials published after 2020.13PubMed Central. Skin Tone Representation of Early Lyme Disease in Medical Education Resources: Gaps and Implications for Equity
This imbalance in training materials can contribute to diagnostic delays in patients with darker skin. The rash still behaves the same way: it expands outward, may feel warm, and follows the typical timeline. But if a clinician has only ever seen erythema migrans depicted as a vivid red circle on pale skin, they may not recognize the same process presenting as a dusky patch on a darker background. If you have darker skin and find an expanding warm area at the site of a tick bite, pointing that out explicitly to your doctor can help, even if the color does not match the textbook images.
Treatment and How Quickly It Works
Erythema migrans is highly treatable when caught early. First-line therapy is a course of oral antibiotics, with doxycycline being the most commonly prescribed. Amoxicillin and cefuroxime axetil are alternatives, particularly for children, pregnant individuals, or those who cannot take doxycycline. A systematic review of treatment evidence supports courses lasting 10 to 21 days, though the optimal length remains debated.14PubMed. Systematic review of the treatment of early Lyme disease
In a randomized trial comparing cefuroxime axetil to doxycycline, a satisfactory outcome at one month was seen in about 93% of patients on cefuroxime and 88% on doxycycline. At the one-year follow-up, those numbers held steady, with roughly 90% of patients in both groups maintaining good outcomes.15PubMed. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease The rash itself typically begins to fade within days of starting antibiotics, though complete resolution can take a couple of weeks.
Macrolide antibiotics like azithromycin are considered second-line options. They work, but evidence suggests they are somewhat less effective than the first-line choices.16PubMed. Systematic review of the treatment of early Lyme disease The key message is that early treatment almost always works well. The infection becomes harder to manage the longer it goes untreated and the further it spreads beyond the skin.
What Happens Without Treatment
Left alone, erythema migrans will eventually fade on its own, but this does not mean the infection has cleared. The spirochete can spread to the joints, nervous system, and heart. Late-stage manifestations include Lyme arthritis (painful swelling, usually in a large joint like the knee), neurological problems such as facial palsy or meningitis, and less commonly, heart conduction abnormalities. A separate late skin manifestation seen primarily in European cases, called acrodermatitis chronica atrophicans, produces a chronic thinning and discoloration of the skin, usually on the hands or feet.17PubMed Central. Lyme Disease: An Overview These late complications are far more difficult to treat than early-stage disease, which is a major reason the erythema migrans rash is so clinically important: it is often the body’s clearest and most accessible signal that something needs to be addressed right now.
Even with proper antibiotic treatment, roughly 10% of patients go on to experience lingering symptoms, a condition known as posttreatment Lyme disease syndrome. Fatigue, cognitive difficulties, chronic pain, and sleep problems are the most common complaints, and they can persist for months or longer.18PubMed Central. Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis The cause of this syndrome is still debated, with theories ranging from residual immune activation to persistent low-level infection, but additional rounds of antibiotics have not been shown to help in controlled trials.
How the Tick Helps the Bacterium Evade Your Immune System
The relationship between the tick and Borrelia is not just a matter of physical transport. Tick saliva actively suppresses the skin’s immune defenses during the feeding process. In mouse models, when Borrelia was injected by syringe without tick saliva, the skin mounted a vigorous inflammatory response. But when the same bacteria were delivered through an actual tick bite, key inflammatory genes were significantly dampened.19PubMed. Tick saliva represses innate immunity and cutaneous inflammation in a murine model of Lyme disease The spirochete essentially rides into the body under the cover of the tick’s own immune-suppressing toolkit.
More recent work has shown that tick saliva also affects Langerhans cells, the immune sentinels that patrol the outer layer of skin. Rather than activating these cells to fight the invader, tick saliva pushes them toward a tolerant state, meaning they are less likely to sound the alarm or help the body form a strong immune memory against the pathogen.20Nature Communications. Human epidermal Langerhans cells induce tolerance and hamper T cell function upon tick-borne pathogen transmission This immune evasion is part of why erythema migrans can take days or weeks to appear: the bacteria have time to establish themselves before the immune system catches on.
Coinfections From the Same Tick Bite
Blacklegged ticks can carry more than just Borrelia. The same tick that transmits Lyme disease may also harbor Anaplasma phagocytophilum (which causes human granulocytic anaplasmosis), Babesia microti (which causes babesiosis), or other pathogens. A coinfection can complicate the clinical picture, potentially making symptoms worse or adding features like high fever and low blood cell counts that are not typical of Lyme disease alone.
That said, research on Lyme and anaplasmosis coinfection has found the overlap is not always as dramatic as feared. In one study, patients with both infections had only modestly more symptoms than those with Lyme disease alone, and high fever and low blood counts were actually less common in the coinfected group than in patients who had anaplasmosis by itself.21PubMed. Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity The practical point is that if your symptoms after a tick bite seem unusually severe or include features not normally associated with Lyme, your clinician should consider testing for additional tick-borne infections rather than assuming everything is from Borrelia.
What a Skin Biopsy Shows
Biopsy of an erythema migrans lesion is not usually necessary for diagnosis, but when one is performed, the findings are characteristic even though they are not unique to Lyme disease. The tissue typically shows clusters of immune cells, especially lymphocytes and plasma cells, gathered around small blood vessels in the dermis. The presence of plasma cells in an annular (ring-shaped) skin lesion is a strong clue pointing toward erythema migrans, since many of the conditions that mimic it on the surface do not produce this particular pattern under the microscope.22PubMed. Histopathology of lyme borreliosis This kind of tissue examination is most useful in ambiguous cases where the rash does not look typical and the clinical history is uncertain.
A Brief History of the Rash
Erythema migrans was described long before anyone knew what caused it. Swedish dermatologist Arvid Afzelius presented the first documented case in 1909, noting an expanding ring-shaped rash following a tick bite. The connection to an underlying infection took decades to piece together. It was not until 1982 that Willy Burgdorfer identified spirochete bacteria in ticks from areas where Lyme arthritis was endemic, establishing the causal link and giving the organism its name, Borrelia burgdorferi.23PubMed. Willy Burgdorfer: Lyme disease For over 70 years, clinicians observed the rash without knowing what was driving it, which goes a long way toward explaining why so much early medical imagery emphasized the most visually distinctive bull’s-eye form: it was the pattern easiest to describe and remember in an era before the biology was understood.